Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

The world of science is constantly evolving, driven by human curiosity and the quest for knowledge. New discoveries are made daily, pushing the boundaries of our understanding and opening up fresh ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.

Every face is unique. Genetics helps to determine our features, but sometimes genes have errors which, in early fetal ...

A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life ...

Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell ...

Doctors in the UK have developed a groundbreaking gene therapy using base editing to treat aggressive blood cancers once ...